Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients

Detalles Bibliográficos
Autor principal: Beer, Ilan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315040/
https://www.ncbi.nlm.nih.gov/pubmed/34326832
http://dx.doi.org/10.3389/fimmu.2021.523906
_version_ 1783729656997871616
author Beer, Ilan
author_facet Beer, Ilan
author_sort Beer, Ilan
collection PubMed
description
format Online
Article
Text
id pubmed-8315040
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83150402021-07-28 Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients Beer, Ilan Front Immunol Immunology Frontiers Media S.A. 2021-07-13 /pmc/articles/PMC8315040/ /pubmed/34326832 http://dx.doi.org/10.3389/fimmu.2021.523906 Text en Copyright © 2021 Beer https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Beer, Ilan
Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_full Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_fullStr Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_full_unstemmed Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_short Commentary: An In Silico – In Vitro Pipeline Identifying an HLA-A*02:01(+) KRAS G12V(+) Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
title_sort commentary: an in silico – in vitro pipeline identifying an hla-a*02:01(+) kras g12v(+) spliced epitope candidate for a broad tumor-immune response in cancer patients
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315040/
https://www.ncbi.nlm.nih.gov/pubmed/34326832
http://dx.doi.org/10.3389/fimmu.2021.523906
work_keys_str_mv AT beerilan commentaryaninsilicoinvitropipelineidentifyinganhlaa0201krasg12vsplicedepitopecandidateforabroadtumorimmuneresponseincancerpatients

Ejemplares similares